About Endometrial Hyperplasia
Endometrial hyperplasia is a condition where the lining of the uterus, known as the endometrium, becomes thicker than normal. It is not cancer, but it is considered a precancerous condition because it can potentially develop into uterine cancer. There are different types of endometrial hyperplasia, which are categorized based on changes in the cells of the uterine lining. The two main types are:
- Endometrial hyperplasia without atypia: This type does not typically involve any irregular cells and is the most common and benign form of endometrial hyperplasia.
- Atypical endometrial hyperplasia: This type involves irregular cells, and there is a higher risk of it developing into uterine cancer.
The condition occurs due to an imbalance of hormones, specifically an excess of estrogen without enough progesterone. Treatment usually involves hormone therapy to restore hormonal balance and manage the hyperplasia.
Endometrial hyperplasia is primarily caused by an excess of estrogen in the body, which leads to the thickening of the lining of the uterus.
Non-modifiable risk factors are risk factors that cannot be changed. Non-modifiable risk factors for endometrial hyperplasia include:
- Age: Women over 35 years old are at a higher risk.
- Menopausal status: Postmenopausal women have an increased risk.
- Genetic factors: Certain genetic mutations, such as Lynch syndrome, Cowden syndrome, and Polymerase proof-reading polyposis, can contribute to the development of endometrial hyperplasia.
Modifiable risk factors are risk factors that can be changed or influenced. Modifiable risk factors for endometrial hyperplasia include:
- Obesity: Excess body weight can lead to hormonal imbalances and increase estrogen levels.
- Unopposed estrogen therapy: Using estrogen for hormone therapy without also using progesterone or progestin can increase the risk.
- Irregular periods: Women with irregular menstrual cycles, especially those with polycystic ovary syndrome (PCOS), are at a higher risk.
- Medications: Taking medications like tamoxifen, which act similarly to estrogen, can increase the risk.
It's important to note that these risk factors may vary among different populations. It's recommended to consult with a healthcare professional for personalized advice and guidance.
The most common early symptoms of endometrial hyperplasia include:
- Irregular uterine bleeding, such as heavier or longer periods, shorter menstrual cycles, and bleeding between periods
- Anemia due to excessive bleeding
- Fatigue
It's important to note that not everyone with endometrial hyperplasia will experience all of these symptoms. The intensity, location, and duration of symptoms can vary from person to person. If you suspect you may have endometrial hyperplasia or are experiencing any concerning symptoms, it is recommended to consult with a healthcare professional for an accurate diagnosis and appropriate management.
To diagnose endometrial hyperplasia, doctors commonly perform the following examinations, tests, and procedures:
- Medical history and symptom evaluation: A doctor will ask about your symptoms and medical history to understand your condition better.
- Physical examination: A doctor may perform a physical examination to assess any abnormalities. Women with endometrial hyperplasia usually do not have an enlarged or tender uterus.
- Ultrasound scan: An ultrasound scan is commonly used to measure the thickness of the uterine lining and check for other causes of abnormal bleeding, such as ovarian cysts.
- Endometrial biopsy: If the uterine lining appears thickened, a doctor may recommend an endometrial biopsy. This procedure involves removing a small sample of cells from the lining for further analysis.
- Hysteroscopy: In some cases, a doctor may recommend a hysteroscopy, where a thin camera is inserted into the uterus through the vagina. This allows the doctor to visually examine the uterus for any irregularities and take biopsies if necessary.
- Histopathological examination: A histopathological examination analyzes tissue samples obtained from biopsies or surgical procedures to determine the type and severity of endometrial hyperplasia.
It's important to consult with your healthcare professional for personalized advice on examinations, tests, and procedures specific to your individual situation.
The goals of treatment for endometrial hyperplasia are to:
- Induce regression of endometrial tissue and prevent proliferation:
- Surgical management, specifically laparoscopic treatment with complete excision of fibrotic lesions, is the preferred choice. This procedure offers improved visualization, less blood loss, and reduced adhesion formation. The use of precise techniques like carbon dioxide laser or plasma jet energy helps minimize potential injury to surrounding structures.
- Prevent progression to ureteral obstruction:
- Surgical management also aims to protect the ureters and surrounding blood vessels. A peritoneal incision is made using a laser in an unaffected area, creating an opening without damaging the ureters.
- Preserve fertility:
- In cases where women wish to become pregnant or cannot undergo surgery due to contraindications, conservative treatment can be considered. This may involve hormonal therapy, which limits endometrial growth by reducing estrogen stimulation. The specific type of hormone therapy used varies but aims to shrink endometriosis tissue.
It's important to note that the information provided is based on general recommendations. Individual treatment plans should be determined by your healthcare professional after considering your specific circumstances.